So this is the crux of the announcement-
“The Company is now actively seeking large pharmaceutical investors or companies to partner with
us in developing and commercialising this research.
If they are so confident about their research results big pharma would be falling all over themselves to get on board. This will either lead to further dilution if they partner, or no interest if the results don't stack up commercially to other players with deep pockets.
Still a long long way to go.
- Forums
- ASX - By Stock
- CGB
- Ann: Research results lead to broader auto-immune research
Ann: Research results lead to broader auto-immune research, page-17
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online